维普期刊资源整合服务平台（V6.5）

158篇 您的检索式：作者名="Schorge"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Bcl-2andp53protein expression,apoptosis and p53 mutation inhuman epithelial ovarian cancers显示文摘	Chan WY Cheung KK Schorge JO	2000	Am J Pathol2000，156，：	1
2	Osteopontin as an ad-junct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	ClinCancer Res2004，10，10：	1
3	Nongenomic actions of progesterone and 17beta-estradiol on the chloride conductance of skeletal muscle显示文摘	Burge JA Hanna MG Schorge S	2013	M uscle Nerve2013，48，4：	1
4	Bcl-2 and p53 Protein Expression,Apoptosis,and p53 Mutation in Human Epithelial Ovarian Cancers显示文摘	Chan WY Cheung KK Schorge JO	2000	Am J Pathol2000，156，：	1
5	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
6	Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits显示文摘	Schorge S Colquhoun D	2003	J Neurosei2003，23，4：	1
7	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge J O Drake R D Lee H	2004	Clin Cancer Res2004，10，10：	1
8	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
9	Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers显示文摘	Chan WY Chetmg KK Schorge JO	2000	Am J Pathol2000，156，2：	1
10	Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in hu- man epithelial ovarian cancers 显示文摘	Chan W Y Cheung K K Schorge J O	2000	Am J Pathol2000，156，2：	1
11	Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix显示文摘	Boruta D M Schorge J O Duska L A	2001	Gynecol Oncol2001，81，1：	1
12	Recent advances in gestational trophoblastic disease 显示文摘	Schorge JO Goldstein DP Bemstein MR	2000	J Reprod Med2000，45，9：	1
13	Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk Women显示文摘	Rathi A Virmani A K Schorge J O	2002	Clin Cancer Res2002，8，15：	1
14	Thinprep detection of cervical and endometrial adenocarcinoma:a retrospective cohort study显示文摘	Schorge JQ Saboorian MH Hynan L	2002	Cancer2002，96，6：	1
15	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
16	Studies of NMDA receptor function and stoichiometry with trtmcated and tandem subunits 显示文摘	Schorge S Colquhoun D	2003	J Neurosci2003，23，4：	1
17	Secondary cytoreductive surgery for recurrent platinum sensitive ovarian cancer显示文摘	Schorge JO Wingo SN Bhore R	2010	Int J Gynaecol Obstet2010，1118，2：	1
18	Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data 显示文摘	Vlahou A Schorge JO Gregory BW	2003	J Biomed Biotechnol2003，2003，5：	1
19	Cytoreductive surgery for ad- vanced ovarian cancer: quo vadis? 显示文摘	Schorge JO Garrett LA Goodman A	2011	Oncology2011，25，10：	1
20	Prognostic determinants in patients with stage ⅢC and Ⅳ uterine papillary serous carcinoma显示文摘	J Alejandro Rauh-Hain Whitfeld B Growdon John O Schorge	2010	Gynecologic Oncology2010，119，2：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示